Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
INNOCARE (810020)
- 0.000
- 0.0000.00%
Market Closed May 15 09:30 CST
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Prev Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares--52wk High0.00P/B0Float Cap--52wk Low--Dividend TTM0Shs Float--Historical High--Dividend LFY0.00%Range %--Historical Low--Avg Price--Lot Size--Div Yield TTM--Div Yield LFY
810020 Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
No Data
810020 Orderflow
Unit: --
810020 Orderflow Trend
IntradayDayWeekMonth
No Data
INNOCARE (810020) News
InnoCare's Immunotherapy Gets First Prescription in China Under Early Access Program
InnoCare Announces First Patient Dosed in Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China
Latest Data of InnoCare's Robust Oncology Pipelines Presented at the 2022 ASCO Annual Meeting
Latest Data of InnoCare's Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022
INNOCARE-B Mulls A-shr Listing on Sci-Tech Board
*M Stanley Ramps up INNOCARE-B (09969.HK) TP to $16.4, Rating Overweight
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"